NASDAQ:JBIO | Cash Flow Statement | Jade Biosciences, Inc.

Complete source-backed cash-flow history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$55.77M
2026-03-31-$40.37M-$24.08M-$8.47M-$795,000.00
2025-12-31-$31.93M-$33.65M$3,000.00-$98.16M$170.16M
2025-09-30-$25.18M
2025-06-30-$32.13M
2025-03-31-$38.17M-$18.76M$12.85M-$700,000.00
2024-12-31-$5.43M-$11.05M$13.13M$554,000.00
2024-09-30-$16.87M-$6.8M$0.00$94.77M
2024-06-30-$24.78M
2024-03-31-$23.19M-$23.67M$8.83M$471,000.00
2023-12-31-$20.41M-$14.8M$64,000.00$5.65M$463,000.00
2023-09-30-$19.56M
2023-06-30-$19.03M
2023-03-31-$16.52M-$11.42M$16,000.00$15.38M$223,000.00
2022-12-31-$15.02M-$14.87M$4,000.00$14.49M$357,000.00
2022-09-30-$13.59M
2022-06-30-$11.99M
2022-03-31-$10.91M-$5.66M$28,000.00-$20.4M
2021-12-31-$8.22M-$13.09M$85,000.00-$113.34M-$250,000.00
2021-09-30-$6.18M
2021-06-30-$5.78M
2021-03-31-$2.78M-$3.78M$40,000.00-$40,000.00$7.88M
2020-12-31-$3.67M-$2.88M$0.00
2020-09-30-$2.31M
2020-06-30-$2.2M
2020-03-31-$1.44M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$127.41M-$94.69M$196,000.00-$247.01M$360.77M
2024-12-31-$69.63M-$71.2M$56.03M$25.43M
2023-12-31-$75.52M-$56.78M$142,000.00$11.88M$46M
2022-12-31-$51.51M-$39.12M$195,000.00$6.93M$396,000.00
2021-12-31-$22.96M-$27.4M$181,000.00-$113.43M$190.46M
2020-12-31-$9.61M-$7.86M$8.92M